Intraspinal Delivery of Polyethylene Glycol-coated Gold Nanoparticles Promotes Functional Recovery After Spinal Cord Injury

Autor: Nafsika Poulia, Nevena Djogo, Horst Weller, Darko Ciric, Gabrielle Loers, Melitta Schachner, Florentia Papastefanaki, Florian Schulz, Tamara Martinovic, Rebecca Matsas, Tobias Vossmeyer, Igor Jakovcevski
Jazyk: angličtina
Rok vydání: 2015
Předmět:
drug effects [Recovery of Function]
chemistry [Coated Materials
Biocompatible]

Central nervous system
chemistry [Gold]
Metal Nanoparticles
Polyethylene glycol
Hindlimb
Pharmacology
pharmacology [Polyethylene Glycols]
Polyethylene Glycols
chemistry.chemical_compound
Mice
Drug Delivery Systems
Coated Materials
Biocompatible

drug therapy [Spinal Cord Injuries]
PEG ratio
Drug Discovery
chemistry [Metal Nanoparticles]
Genetics
Medicine
Animals
ddc:610
Spinal cord injury
Molecular Biology
Spinal Cord Injuries
pharmacology [Coated Materials
Biocompatible]

business.industry
pharmacology [Gold]
methods [Drug Delivery Systems]
Recovery of Function
Motor neuron
medicine.disease
3. Good health
Mice
Inbred C57BL

Disease Models
Animal

medicine.anatomical_structure
chemistry [Polyethylene Glycols]
chemistry
Toxicity
Drug delivery
Molecular Medicine
Original Article
Female
Gold
business
Zdroj: Molecular therapy 23(6), 993-1002 (2015). doi:10.1038/mt.2015.50
DOI: 10.1038/mt.2015.50
Popis: Failure of the mammalian central nervous system (CNS) to regenerate effectively after injury leads to mostly irreversible functional impairment. Gold nanoparticles (AuNPs) are promising candidates for drug delivery in combination with tissue-compatible reagents, such as polyethylene glycol (PEG). PEG administration in CNS injury models has received interest for potential therapy, but toxicity and low bioavailability prevents clinical application. Here we show that intraspinal delivery of PEG-functionalized 40-nm-AuNPs at early stages after mouse spinal cord injury is beneficial for recovery. Positive outcome of hind limb motor function was accompanied by attenuated inflammatory response, enhanced motor neuron survival, and increased myelination of spared or regrown/sprouted axons. No adverse effects, such as body weight loss, ill health, or increased mortality were observed. We propose that PEG-AuNPs represent a favorable drug-delivery platform with therapeutic potential that could be further enhanced if PEG-AuNPs are used as carriers of regeneration-promoting molecules.
Databáze: OpenAIRE